US Patent Issued to Poseida Therapeutics on Sept. 16 for "BCMA specific VCAR compositions and methods for use" (California Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,844, issued on Sept. 16, was assigned to Poseida Therapeutics Inc. (San Diego).

"BCMA specific VCAR compositions and methods for use" was invented by Eric M. Ostertag (San Diego) and Devon Shedlock (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are VHH chimeric antigen receptors (VCARs), VCAR transposons encoding VCARs of the disclosure, cells modified to express VCARs of the disclosure, as well as methods of making and methods of using the same for adoptive cell therapy."

The patent was filed on Dec. 20, 2018, under Application No. 16/772,262.

*For further information, including images, charts and tables, please visit: http:...